MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Pain"

  • 2018 International Congress

    Sensory signs and neuropathic pain in advanced Parkinson’s disease under levodopa treatment

    A.E. Elia, G. Devigili, M. Damasco, L.M. Romito, P. Soliveri, S. Rinaldo, M. Falsitta, R. Eleopra (Milan, Italy)

    Objective: To evaluate whether patients affected by Parkinson’s disease (PD) under levodopa/carbidopa intestinal gel (LCIG) therapy have alterations in sensory symptoms and signs and/or painful…
  • 2018 International Congress

    The association between pain and physical activity in people with Parkinson’s Disease (PD)

    H. Khalil, A. Al-Sharman, N. Alissa, K. El-Salem, D. Al-Shorafat (Irbid, Jordan)

    Objective: To determine the relationship between pain and physical activity in people with PD Background: Pain in PD is a serious problem that is usually…
  • 2018 International Congress

    Assessment of pain and its correlation with quality of life in Parkinson’s disease

    K. Anand, A. Agrawal, P. Kumar (New Delhi, India)

    Objective: The study was carried out to assess the prevalence of pain, nature of pain, quality of life and correlation of pain with quality of…
  • 2018 International Congress

    Enhanced cingulate activity while anticipating pain – evidence for altered ‘top down’ processing of pain in PD

    S. Martin, A. Jones, C. Brown, C. Kobylecki, M. Silverdale (Manchester, United Kingdom)

    Objective: To investigate the hypothesis that altered ‘top down’ processing contributes to the development of pain in Parkinson’s disease (PD). Background: Altered ‘top down’ processing…
  • 2018 International Congress

    A detailed clinical study of pain in 1957 participants with Parkinson’s disease

    M. Silverdale, C. Kobylecki, L. Kass-Iliyya, P. Martinez-Martin, D. Grosset, M. Hu, M. Lawton, S. Cotterill, R. Chaudhuri, H. Morris, F. Baig, N. Williams, L. Hubbard (Manchester, United Kingdom)

    Objective: We performed a large clinical study to investigate potential factors contributing towards pain in Parkinson’s disease (PD). Background: The causes of pain in PD…
  • 2017 International Congress

    Central pain processing in “drug-naïve” pain-free patients with Parkinson’s disease

    R. De Micco, A. Russo, F. Esposito, A. Giordano, M. Fratello, G. Caiazzo, M. Cirillo, G. Tedeschi, A. Tessitore (Naples, Italy)

    Objective: To investigate whether central pain processing is altered in “drug-naive” pain-free Parkinson disease (dnPD) patients. Background: Despite its clinical relevance, the pathophysiology of pain…
  • 2017 International Congress

    Occupational Therapy for patients with Parkinson’s disease in the context of Bangladesh

    R. Hoque (Dhaka, Bangladesh)

    Objective: To determine impact of Occupational Therapy for patients with Parkinson’s disease in the context of Bangladesh. Background: Patients with Parkinson’s disease are always at risk…
  • 2017 International Congress

    Safinamide improves both motor and non-motor symptoms in fluctuating Parkinson’s Disease patients.

    C. Cattaneo (Bresso (Milan), Italy)

    Objective: To investigate the efficacy of safinamide, compared to placebo, as add-on therapy to stable doses of levodopa, on both motor and non-motor symptoms in…
  • 2017 International Congress

    Interrelation between chronic pain syndrome and cognitive and affective disturbances in patients with Parkinson’s disease

    K. Stepanchenko (Kharkiv, Ukraine)

    Objective: To study interrelation of chronic pain syndrome and cognitive and affective disorders in patients with PD Background: Parkinson's disease (PD) is characterized by well-known…
  • 2017 International Congress

    Assessment of pain in Parkinson’s disease: comparison between clinical and self-reported measures

    C. Rodriguez-Blazquez, R. Balestrino, K. Chaudhuri, J.M. Rojo-Abuin, A. Rizos, C. Trenkwalder, A. Sauerbier, P. Odin, A. Antonini, P. Martinez-Martin (Madrid, Spain)

    Objective: To compare the performance of several pain measures, self- and rater-based, in PD patients. Background: Pain is a prevalent and complex symptom in Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 19
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley